3Longhurst PA,Brotcke TP,Leggett RE,et al.The influence of streptozotocin-induced diabetes mellitus on the sensitivity of rat urinary bladder body and hase strips to changes in extracellular calcium[J].Gen Pharmacol,1992,23:83～88.
4Ichiyanagi N,Tsujii T,Masuda H,et al.Changed responsiveness of the detrusor in rabbits with alloxan induced hyperglycemia:possible role of 5-hydroxytryptamine for diabetic bladder dysfunction[J].J Urol,2002,168:303～307.
5Hotta N.New concepts and insights on pathogenesis and treatment of diabetic complications:polyol pathway and its inhibition [J].Nagoya J Med Sci,1997,60:89-100.
6Latifpour J,Nishimoto T,Marian MJ,et al.Differential regulation of bladder beta-adrenergic and muscarinic cholinergic receptors in experimental diabetes[J].Diabetes,1991,40:1150-1156.
7Menendez V,Cofan F,Talbot-WrightR,et al.Urodynamic evaluation in simultaneous insulin-dependent diabetes mellitus and end stage renal disease[J].Clin Urol,1996,155:2001-2004.
8Luheshi GN,Zar MA.The effect of streptozotocin-induced diabetes on cholinergic motor transmission in the rat urinary bladder[J].Br J Pharmacol,1991,103:1657-1662.
9Hotta N,Kakuta H,Fukasawa H,et al.Effect of a potent new aldose reductase inhibitor,(5-3-thienyltetrazol-1-yl)acetic acid(TAT),on diabetic neuropathy in rats[J].Diabetes Res Clin Pract,1995,27:107-117.
10Nakamura J,Hamada Y,Chaya S,et al.Transition metals and polyol pathway in the development of diabetic neuropathy in rats [J].Diabetes/Metab Res Rev,2002,18:395-402.
